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Abstract
Background: There is limited evidence on caregiver outcomes associated with mild cognitive impairment in patients
with Parkinson’s disease (PD-MCI) and the coping strategies used by these caregivers.
Methods: To investigate this relationship, we examined levels of burden, depression, anxiety, coping strategies
and positive aspects of caregiving in the informal caregivers of 96 PD patients. The PD patients were classified
using MDS-Task Force Level II criteria as showing either normal cognition (PD-N; n = 51), PD-MCI (n = 30) or
with dementia (PDD; n = 15).
Results: Mean Zarit Burden Interview (ZBI) score increased significantly between carers of PD-N (M = 13.39, SD = 12.22)
compared to those of PD-MCI patients (M = 22.00, SD = 10.8), and between carers of PD-MCI and PDD patients
(M = 29.33, SD = 9.59). Moreover, the proportion of carers showing clinically significant levels of burden (ZBI
score ≥ 21) also increased as the patients’ cognitive status declined (18% for PD-N; 60% for PD-MCI; and 80% for
PDD) and was mirrored by an increasing amount of time spent providing care by the caregivers. Caregiver ZBI
score was independent of patient neuropsychiatric symptoms, motor function, disease duration and time that
caregivers spent caregiving. Caregiver use of different coping strategies increased with worsening cognition. However, we
found only equivocal evidence that the use of problem-focused, emotion-focused and dysfunctional coping mediated
the association between patient cognitive status and caregiver burden, because the inverse models that used caregiver
burden as the mediator were also significant.
Conclusions: The study highlights the impact of Parkinson’s disease on those providing care when the patient’s
cognition is poor, including those with MCI. Caregiver well-being has important implications for caregiver
support, nursing home placement and disease course.
Keywords: Parkinson’s disease, Mild cognitive impairment, Zarit caregiver burden interview, Coping, Depression, Anxiety,
Positive aspects of caregiving
Background
Cognitive problems are an integral part of Parkinson’s
disease because dementia (PDD) eventuates in 75%–90%
of patients and is associated with substantial health and
economic burden [1]. Patients who present with mild
cognitive impairment (PD-MCI) are at high risk of
progression to PDD and are a growing research focus to
assess the impact of increasing cognitive impairment
and to facilitate early intervention [2–5]. The impact of
cognitive status on the informal caregiver is a relatively
neglected dimension of PD-MCI and there is limited re-
search on the specific effects of cognitive decline on the
well-being of caregivers of these PD patients. Under-
standing these relationships is important because im-
proving caregiver support and well-being may have a
bearing on disease management and delay formal care
and nursing home placement.
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It is well-established that there is higher caregiver
burden and reduced quality of life in caregivers once de-
mentia onset has commenced in PD [6, 7]. Recent as-
sessments of well-being in PD-MCI caregivers has
revealed mixed results, in that reduced quality of life
measures were found in these caregivers [8] but explicit
measures of burden using the Zarit Burden Interview
(ZBI), did not show elevated levels of burden for PD-
MCI caregivers as compared to PD-N caregivers [9, 10].
Such results contrast with reports of increased caregiver
burden in carers of people with MCI who are at risk of
Alzheimer’s dementia [11], although additional factors
may contribute to PD caregiver difficulties [12]. The fai-
lure to find increased Zarit burden scores in carers of
PD-MCI patients is unexpected, but may reflect the
over-riding impact of motor disabilities and other non-
motor symptoms in PD even prior to dementia.
The Zarit Burden Interview provides a well-validated
global measure of the physical, emotional and socioeco-
nomic impact of caring for neurologically compromised
individuals [13]. While motor and neuropsychiatric
symptoms present one explanation of the response of
the caregiver to the patient with PD, an alternative rea-
son for the failure to identify increased burden with PD-
MCI patients may be that caregiving strategies develop
within the context of ostensibly a movement disorder
that has a dominant influence on the interaction be-
tween patient and caregiver. For example, the response
by caregivers to the presence of MCI in the context of
an already established disease such as PD may evoke
compensatory positive attitudes in carers or may influ-
ence their coping strategies before problems associated
with dementia become overwhelming. In the wider li-
terature in the context of dementia, the use of three
coping strategies (problem-focused, emotion-focused
and dysfunctional coping) has been found useful to ex-
plain variability in caregiver outcomes in that dementia
caregivers who use more emotion-focused coping and
less dysfunctional coping express lower anxiety and de-
pression [14]. Dysfunctional strategies include substance
use, distraction, and disengagement, while emotion-
focused coping concerns attempts to reduce distress by
regulating emotions which may prove adaptive in the
context of PD caregiving. Problem-focused coping re-
lates to managing distress through confronting and alte-
ring the situation, but findings for this strategy are less
clear [14]. Identifying these strategies has the benefit of
providing a focus for interventions to improve caregiver
well-being [15, 16]. We therefore examined caregiver
coping strategies and positive aspects of caregiving as
potential mediators of the relationship between patients’
cognitive status and caregiver burden.
In the current study we employed a cross-sectional
design to examine burden expressed by caregivers of
patients who met the current Movement Disorders
Society – Task Force (MDS-TF) Level II criteria for PD-
MCI and PDD [17, 18] and by caregivers of patients with
normal levels of cognition (PD-N). Previous studies that
assessed caregivers of PD-MCI patients employed Level
I criteria, in which the range of tests employed are re-
stricted either to global measures of cognition or a rela-
tively restricted range of cognitive measures [8–10]. We
have found that specific Level II criteria, in which two
impairments are required within a single domain, cap-
ture PD-MCI patients who are at greatest risk of decline
to PDD in the subsequent 4 years [4] and who may thus
pose a greater challenge to caregiver well-being. The
MDS-TF level II criteria also enabled an assessment of
caregiver outcomes associated with PD-MCI subtypes
[10] including attentional deficits, which have been
shown to be associated with lower Quality of Life in PD
carers [8].
We hypothesized that caregivers of patients meeting
Level II PD-MCI criteria would express a level of burden
(ZBI) that was intermediate to that experienced by PD-N
and PDD caregivers. It was also anticipated that atten-
tional deficits in PD patients would be associated with
increased caregiver burden [10]. Further, it was hypothe-
sized that, similar to Alzheimer’s caregivers, [19] use of
emotion-focused-coping strategies would reduce this level
of distress (ZBI) but that use of problem-focused coping
and dysfunctional coping would not.
Methods
A convenience sample of 96 PD patients (UK Parkinson’s
Society criteria), part of a longitudinal study, were re-
cruited through the New Zealand Brain Research Institute.
Caregivers were identified as any person who was directly
involved in the patient’s care and provided some form of
support with respect to everyday activities. These care-
givers either lived with the patients (n = 82), were spouses,
partners or children and spent a minimum of 4 hours per
week caring for the patient. At the time when caregivers
were interviewed for this study, 15 patients met criteria
for PDD, while the remaining PD patients were assessed
as showing either PD-MCI (n = 30) or cognitive abilities
within a normal range of scores (PD-N; n = 51). The PD
patients met MDS-TF level II criteria by completing
neuropsychological assessments over 2 sessions using 23
measures across the recommended five cognitive domains
(attention, working memory and processing speed; execu-
tive function; visuoperceptual/visuospatial; learning and
memory; language) within 6 months of the caregiver bur-
den and coping assessments. A diagnosis of PD-MCI was
confirmed when any two (or more) impaired neuro-
psychological test scores were present within any single
domain but everyday independent function as reported by
the caregiver [20] was generally preserved and indicated
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cognitive independence. A score 1.5SD or more below
normative data was considered an impaired score [4].
Evidence of PDD was determined when the caregiver re-
ported inability by the patient on everyday tasks in the
context of impaired cognition in two or more cognitive
domains [20], which was supplemented by assessment of
the patient’s performance during interview and caregiver
responses on the neuropsychiatric inventory (NPI) [21].
Motor function was assessed with the Unified Parkinson’s
disease Rating Scale part III (UPDRS-III) [22]. All patients
were in an ‘on’ state during neuropsychological assess-
ment. Table 1 provides individual neuropsychological test
and domain scores for the three patient groups. Caregiver
demographical information and clinical characteristics of
the caregivers and patients are provided in Tables 2 and 3.
Measures
The Zarit burden interview (ZBI)
This 22-item scale identifies the impact of the patient’s
disability in terms of caregiver health, finances, emotion,
social life and interpersonal relations [13]. For each item,
the caregiver rates how often they have felt the sug-
gested feeling or perception, from never (score 0) to
nearly always (score 4), generating a score ranging from
0 to 88. In dementia caregivers, the measure has good
internal consistency with a Cronbach’s alpha of .92. A
score ≥ 21 signifies mild to moderate burden [13].
The brief coping orientations for problems experienced
(COPE)
This 28-item version of the 60-item inventory assesses
coping strategies [23]. Caregivers were asked to consider
their current PD-caregiving situation. Responses were
scored on a 4-point Likert scale ranging from ‘I usually
don’t do this at all’ through to ‘I usually do this a lot’.
Principal component factor analysis identified three di-
mension scores involving problem-focused, emotion-
focused and dysfunctional coping (Additional file 1:
Table A and Table B).
Positive aspects of caregiving (PAC)
This 9-item instrument provided a positive dimension
score of the caregiving experience [24].
Depression/anxiety
The 15-item Geriatric Depression Scale (GDS) [25] was
used to screen for depressive symptoms in caregivers
and patients while anxiety symptoms in caregivers were
assessed with the Geriatric Anxiety Inventory (GAI) [26].
Hours per week spent caregiving
Caregivers were asked to estimate the average amount of
time they spent each day providing care to the PD pa-
tient, which was multiplied by 7 to give a total of hours
per week. Caregivers were asked to consider the provision
of care relating to PD symptoms.
Neuropsychiatric inventory
The Neuropsychiatric Inventory (NPI) [21] assesses 10
behavioural disturbances: delusions, hallucinations, dys-
phoria, anxiety, agitation/aggression, euphoria, disinhi-
bition, irritability/lability, apathy, and aberrant motor
activity. Information for the NPI is obtained from the
caregiver about the patient’s behaviour. Only those do-
mains with positive responses to screening questions are
used for scoring. The frequency of the symptoms is
scored on a 4-point scale, severity on a 3-point scale,
and distress caused by the patient’s symptoms on a
5-point scale.
Activities of daily living – International scale
The Activities of Daily living – International scale (ADL-
IS) [20] consists of 40 questions such as “Does [the
patient] have difficulty putting household items in the
right places?” to which the informant is asked to re-
spond using a Likert scale of 0 = ‘never has difficulty’
to 3 = ‘always has difficulty’. A response of 4 = ‘activity no
longer performed (ie. has given up initiating the activity)’;
8 = ‘activity was never performed’ and 9 = ‘unknown’. A
score between 0 and 4 is generated based on the number
of items that the patient was known to perform prior to
their illness.
Statistical analysis
All variables in the study were screened for outliers and
deviations from normality. Single outliers were detected
for disease duration, Hoehn & Yahr score, caregiver age
and the ZBI. Since none of the results changed when
outliers were excluded from analysis, it was decided to
retain these data points. The distribution of the GDS
(patient and caregiver), the NPI, hours of caregiving and
the GAI violated assumptions of normality. A log trans-
formation was used to ensure that skewness and kurtosis
of these variables were within the acceptable range
(means and standard deviations prior to transformation
are presented in the tables to assist interpretability).
Comparison of demographic and clinical variables across
the three cognitive status groups, for both patients and
caregivers, was assessed using Analysis of Variance
(ANOVA) and Chi square. Newman-Keuls (N-K) tests
for equal group variances and Tamhane’s T2 (T2) tests
for unequal group variances were used for post-hoc
comparisons. Additional analyses of covariance exa-
mined whether any effects of cognitive status on care-
giver burden remained after controlling for patient
clinical variables and time spent caregiving. Pearson’s
correlations between PD patient cognitive status (de-
fined as 1 = PD-N, 2 = PD-MCI, 3 = PD-D) [27],
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Table 1 Neuropsychological assessments used for level II criteria (n = 96)
Patient groups PD-N(n = 51) PD-MCI(n = 30) PD-D(n = 15) Analysis (F2,93)
MoCAa 26.64 ± 2.16 24.53 ± 3.08 21.33 ± 2.32 27.12, p < .0001
Attention, Working Memory and
Processing Speed
DigitsF/B .54 ± 0.93 .14 ± 0.69 −.37 ± 0.64 7.69, p < .01
Digit Ordering −.60 ± 1.06 −1.33 ± 1.10 −2.16 ± 0.89 13.52, p < .001
TEA (Map Search) −.46 ± 0.84 −1.40 ± 0.85 −1.91 ± 0.72 23.6, p < .001
Stroop colour .09 ± 0.80 −.60 ± 1.14 −1.13 ± 1.07 15.03, p < .001
Stroop word .15 ± 0.73 −.34 ± 1.06 −.68 ± 1.07 6.17, p < .01
Trails A .32 ± 0.69 −.41 ± 0.99 −1.7 ± 1.22 8.83, p < .001
Domain Score .01 ± 0.50 −.65 ± 0.51 −1.40 ± 0.52 47.78, p < .001
Domain Pass/Fail 51/0 13/17 2/13
Executive Function
Letter Fluency .61 ± 1.45 .28 ± 1.24 −.42 ± 1.40 3.32, p < .05
Action Fluency −.78 ± 1.08 −1.45 ± 1.09 −1.76 ± 1.03 6.56, p < .01
Category Fluency .68 ± 1.14 .07 ± 1.09 −.95 ± 1.17 12.55, p < .001
Category Switching .27 ± 1.12 −.52 ± 1.27 −1.95 ± .89 22.80, p < .001
Trails B .28 ± 0.83 −.30 ± 1.13 −2.31 ± 0.84 44.03, p < .0001
Stroop Interference .31 ± 1.04 −.45 ± 0.78 −1.66 ± 0.70 35.01, p < .0001
Domain Score .23 ± 0.74 −.40 ± 0.72 −1.05 ± 0.55 36.05, p < .0001
Domain Pass/Fail 51/0 15/15 2/13
Learning & Memory
CVLT Free recall .59 ± 1.13 −.29 ± 0.96 −1.44 ± 0.90 23.26, p < .001
CVLT Short delay .31 ± 1.32 −.33 ± 1.28 −1.43 ± 0.53 12.17, p < .001
CVLT Long delay .38 ± 0.90 −.23 ± 0.98 −.76 ± 0.53 11.38, p < .001
Rey Immediate .59 ± 1.71 −.56 ± 1.08 −1.34 ± 1.03 12.84, p < .001
Rey Delayed .58 ± 1.77 −.85 ± 1.15 −1.82 ± 1.08 18.13, p < .001
Domain Score .50 ± 1.06 −.45 ± 0.80 −1.41 ± 0.46 28.50, p < .0001
Domain Pass/Fail Visuospatial 51/0 24/6 4/11
JOL −.15 ± 0.81 −.99 ± 0.81 −.94 ± 0.84 10.55, p < .001
Fragmented letters .62 ± 0.58 .10 ± 9.99 .20 ± .08 7.9, p < .05
Rey Copy .02 ± 1.04 −.85 ± 1.27 −1.61 ± 1.11 14.11, p < .01
Domain Score .44 ± 0.55 −.31 ± 0.63 −.76 ± 0.57 31.94, p < .0001
Domain Pass/Fail 51/0 26/4 11/4
Language
Boston Naming .21 ± 0.86 .05 ± 1.07 −.11 ± 1.21 F2,64 = .87, p = .42
ADAS-Cog .01 ± 0.65 −.18 ± 0.78 −1.16 ± 0.59 14.89, p < .001
DRS-2 .01 ± 0.57 −.18 ± 0.66 −.62 ± 0.88 5.45, p < .01
Domain Score .06 ± 0.47 −.10 ± 0.46 −.67 ± 0.57 13.64, p < .001
Domain Pass/Fail 51/0 29/1 14/1
Global neuropsychological z score .29 ± 0.57 −.45 ± 0.41 −1.29 ± 0.41 62.23, p < .001
Values reported as mean ± standard deviation
aMoCA Montreal Cognitive Assessment, with one missed test; Age and education z scores for all tests except MoCA; global performance was expressed by an
aggregate z score by first averaging standardized scores within four cognitive domains and then taking the mean of these four values; the language domain
scores were not included in this z score due to the distributions of the normative data
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caregiver burden and the three coping strategies were
assessed to see whether criteria for path analysis (me-
diation) were met. The PROCESS macro developed by
Hayes [28] was used to test for mediation using linear
regression. In this procedure the mediated effect (indi-
rect effect) is calculated via bootstrapping using a 95%
confidence interval (CI) [29]. A mediator is significant
when the 95% CI does not include zero. Separate ana-
lyses for each of the three coping strategies as intended
mediators were conducted. Reverse causation, with
caregiver burden as the mediator, was also assessed. All
analyses employed an alpha level of p < 0.05 and were
two-tailed.
Results
Patients in the 3 cognitive status groups did not differ
significantly in mean age, years of education, depression
symptoms or disease stage (Table 2). There were, how-
ever, significant differences between the three groups in
neuropsychiatric inventory (NPI) symptoms, abilities at
everyday tasks (ADL-IS score), motor features (UPDRS
III score) and disease duration. Scores for these patient
measures increased linearly from PD-N to PD-MCI
through to PDD, with significant differences between the
PD-N versus the PDD groups on all measures apart
from disease duration, and between PD-MCI and PDD
on the ADL-IS.
Table 2 Demographic and clinical characteristics of the Parkinson’s disease patient groups n = 96
Patient groups PD-N
(n = 51)
PD-MCI (n = 30) PDD
(n = 15)
Analysis Significant post-hoc differences (N-K or T2)
Age 68.23 ± 7.60 69.5 ± 6.86 72.73 ± 4.85 F2,93 = 2.39, p = .09
Female: Male 16/35 9/21 3/12 X2 = .74, p = .69
Education (yrs) 13.14 ± 3.03 12.56 ± 1.99 12.26 ± 2.49 F2,93 = .82, p = .44
GDS 1.45 ± 2.88 0.73 ± 1.79 2.13 ± 3.14 F2,93 = 1.29, p = .28
H&Y 2.10 ± 0.52 2.30 ± 0.75 2.33 ± 0.59 F2, 90 = 1.48, p = .23
NPI 3.14 ± 5.21 4.37 ± 4.62 8.13 ± 9.26 F2, 89 = 4.83, p < .05 PD-N v PDD, p < .05
ADL-IS .51 ± 0.51 .78 ± 0.47 2.04 ± 0.54 F2,91 = 55.35, p < .0001 PD-N v PDD, p < .001
PD-MCI v PDD, p < .001
Disease Duration (yrs) 7.54 ± 4.00 9.10 ± 4.44 11.63 ± 6.92 F2, 93 = 4.59, p < .05
UPDRS-III 25.64 ± 10.80 29.2 ± 13.07 34.83 ± 10.42 F2,92 = 3.84, p < .05 PD-N v PDD, p < .05
Values reported as mean ± standard deviation: GDS-Geriatric Depression Scale; H&Y- Hoehn & Yahr; NPI - Neuropsychiatric Inventory; ADL-IS Activities of
Daily Living - International Scale (max = 4.0); UPDRS-III Unified Parkinson’s Disease Rating Scale Part III
Table 3 Demographic and clinical characteristics of the caregivers (n = 96)






Analysis Significant post-hoc differences (N-K or T2)
Age 65.53 ± 9.68 62.33 ± 13.61 66.87 ± 11.34 F2,93 = 1.07, p = .35
Female/Male 33/18 21/9 12/3 X2 = 0.74, p = .36
Years Education 12.41 ± 2.36 12.33 ± 2.45 11.60 ± 1.88 F2,93 = 0.73, p = .49
Spouse/Othera 47/4 24/6 12/3 X2 = 3.02, p = .22
Lives separately 3 6 5 X2 = 8.04, p = .98
Hours/week caregiving 5.40 ± 14.30 16.47 ± 27.06 25.01 ± 27.23 F2,93 = 10.17, p < .001 PD-MCI v PDD, p < .05
PD-N v PDD, p < .001
Zarit Burden Interview 13.39 ± 12.22 22.00 ± 10.86 29.33 ± 9.59 F2,93 = 13.89, p < .001 PD-N v PD-MCI, p < .01
PD-N v PDD, p < .001
PD-MCI v PDD, p < .05
Coping Strategies
Problem-Focused 1.88 ± .67 2.20 ± .62 2.35 ± .65 F2,93 = 4.09, p < .05 PD-N v PDD, p < .05
Emotion-Focused 1.93 ± .55 2.24 ± .64 2.27 ± .47 F2,93 = 3.61, p < .05
Dysfunctional 1.28 ± .40 1.43 ± .38 1.55 ± .37 F2,93 = 3.32, p < .05 PD-N v PDD, p < .05
GDS 1.21 ± 1.94 0.73 ± 1.41 0.40 ± .83 F2,93 = 1.59, p = .21
GAI 2.47 ± 3.85 2.47 ± 3.81 0.80 ± 1.61 F2,93 = 1.52, p = .22
Positive Aspects of Caregiving 27.12 ± 8.85 27.316 ± 9.20 24.87 ± 9.36 F2,93 = 0.40, p = .67
Values reported as mean ± standard deviation
aDaughter, son, daughter-in-law, brother or friend
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The caregivers were aged between 23 and 83 years old,
and predominantly a slightly younger spouse (85.4%)
and female (70.8%). Caregivers of the PD patients in the
three cognitive status groups did not differ in mean age,
years of education, positive aspects of caregiving, depres-
sion or anxiety symptoms (Table 3). Caregiver burden
(ZBI), however, increased significantly across the 3 cog-
nitive status groups (F2, 93 = 13.89, p < .00001) with
post-hoc tests (N-K) showing significant differences bet-
ween all 3 groups. Moderate to large effect sizes were
found for the differences between PD-N versus PD-MCI
(Cohen’s d = .73; [CI = .27, 1.20]) and between PD-MCI
versus PDD (Cohen’s d = .70; [CI = .064, 1.33]). A large
effect size was found for the difference between PD-N
versus PDD (Cohen’s d = 1.36; [CI = .74, 1.98]). The pro-
portion of carers showing mild to moderate burden
(ZBI ≥ 21) [13] was 18% for PD-N, 60% for PD-MCI and
80% for PDD; these proportions were significantly diffe-
rent to chance (χ2 = 32.45, p < .0001). There were no
significant correlations between caregiver ZBI or coping
strategies and any of the five individual cognitive domain
scores used to assess the PD-MCI group. Mean caregiver
ZBI scores did not differ significantly when PD-MCI pa-
tients were subdivided according to possible cognitive
subtypes: PD-MCI with attention deficit only, n = 10,
M = 20.9 (SD = 12.88); executive only, n = 8, M = 24.15
(SD = 6.22); memory only, n = 4, M = 25.25 (SD = 20.13);
visuoperception only, n = 1; and any multidomain im-
pairments, n = 7, M = 19 (SD = 8.18). Lack of clear
effects of multidomain were also evident when the
multidomain classification focused on either attention
plus any other domain, n = 7, M = 19 (SD = 8.18) or
executive plus any other domain, n = 7, M = 19
(SD = 8.18), although there was some suggestion of
less burden than the multidomain impairment derived
from memory plus any other domain, n = 2, M = 8.5
(SD = .71) and visuoperceptual plus any other domain,
n = 3, M = 15.33 (SD = 5.5).
The number of hours that caregivers spent per week
caring for PD patients also increased significantly for
caregivers across the 3 cognitive status groups (Table 3).
Post-hoc tests (T2) confirmed significant differences in
time spent caregiving between PD-MCI versus PDD:
medium to large effect size, Cohen’s d = .74 [CI = .09,
1.37]) and PD-N versus PDD: large effect size, Cohen’s
d = 1.49 [CI = .86, 2.11), but the difference between
PD-N versus PD-MCI did not reach significance:
Cohen’s d = .43 [CI = −.04, .88].
Additional covariance analyses showed that the significant
effect of patient cognitive status on the ZBI scores remained
after controlling for disease duration (F(2,92) = 9.16, p < .001),
patient neuropsychiatric symptoms [NPI] (F(2, 88) = 16.04,
p < .001), ability to perform everyday tasks [ADL-IS] (F(2,
88) = 6.70 p < .05), motor difficulties (UPDRS-III) (F(2,
91) = 12.74, p < .001) and even time spent caregiving (F(2,
92) = 9.09, p < .001). There was no difference in ZBI scores be-
tween the caregivers of PD-MCI patients who converted to
PDD within 2 years of the caregiver interview compared to
those who did not convert t(5) = 1.8, p = .13. There was also
no difference in ZBI scores between female (M = 19.26,
SE = 1.58) and male (M = 16.17, SE =2.15) caregivers (t = 1.15,
p = 2.00) and no significant interaction between the ef-
fects of patient cognitive status and gender of caregiver
(F(2, 92) = .60, p = .43).
One aim of this study was to examine whether coping
strategies may provide a mechanism to explain variabi-
lity in caregiver outcomes. There were significant diffe-
rences across the groups in the use of problem-focused,
emotion-focused and dysfunctional coping (Table 3).
Post-hoc tests (N-K) identified significant differences
between PD-N and PDD caregivers only for problem-
focused coping (Cohen’s d = .71[CI = .12, 1.29]) and dys-
functional coping (Cohen’s d = .69 [CI = .10, 1.27]).
There were no differences between the three caregiver
groups in terms of positive aspects of caregiving.
Correlational analyses identified that all 3 coping stra-
tegies correlated with both cognitive status and with
caregiver ZBI score and thus met criteria for path ana-
lysis (Table 4). Support for (partial) mediation requires
that the relationship between cognitive status and care-
giver burden decreases significantly once the mediator is
added to the regression model. A mediator is significant
when the 95% CI of the mediated effect does not include
zero. The bootstrapping procedure provided support for
mediation when problem-focused coping was used as
the intended mediator, (b = 2.02, SE = 0.97, [CI = 0.58,
4.47]). The same was true for the analyses with emotion-
focused coping as the intended mediator (bootstrapping
procedure: b = 0.82, SE = .59, [CI = .06, 2.47]) and dys-
functional coping (b = 2.70 SE = 1.04 [CI = .85–4.94]).
Thus, problem-focused coping, emotion-focused coping
and dysfunctional coping all partially mediated the rela-
tionship between patients’ cognitive status and caregiver
burden (Fig. 1). However, given the cross-sectional na-
ture of our design, it was also necessary to examine the
reverse models in which caregiver burden (ZBI) may in-
stead mediate the relationship between cognitive status
and problem-focused coping, emotion-focused coping
Table 4 Pearson’s correlations between caregiver burden,
cognitive status, and coping strategies (n = 96)
ZBI CogSt P-F Coping E-F Coping
CogSt 0.48***
P-F Coping 0.53*** 0.28**
E-F Coping 0.30*** 0.25* 0.41***
Dysf Coping 0.70*** 0.26** 0.41*** 0.26**
ZBI Zarit burden interview, CogSt Cognitive status, P-F Problem-focused, E-F
Emotion-focused, Dysf = dysfunctional. *p < .05, **p < .01, ***p < .001
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and dysfunctional coping. This reverse analysis was sig-
nificant for all three coping measures: problem-focused:
b = .22 SE = .06 [CI = .12, .37], emotion-focused:
b = .09, SE = .06 [CI = .01, .24], and dysfunctional:
b = .19, SE = .03 [CI = .13, .27]. Given these bidirectional
mediating relationships, we cannot be certain that co-
ping strategies mediated the association between pa-
tient’s cognitive status and caregiver ZBI score.
Discussion
Assessing the impact of PD-MCI on patients and care-
givers is seen as a ‘crucial unmet need’ [18] but has been
scarcely studied. PD patients in the present study were
classified as PD-N, PD-MCI or PDD according to level
II criteria. Unlike previous work using Level I criteria,
we identified increased burden among carers of PD-MCI
patients compared with those of PD-N. Further, PDD
caregivers had significantly higher ZBI scores compared
to both PD-N and PD-MCI caregivers. The use of all
three coping strategies increased as the patient’s cogni-
tive status worsened. There were no differences in terms
of positive caregiving aspects, depression or anxiety
across the carers of the different PD patient groups. The
current study’s ZBI findings on burden in caregivers of
PD-MCI patients are in contrast to previous research by
Leroi et al. [9] and Szeto et al. [10].
Leroi and colleagues identified moderate burden in
PD-MCI caregivers which was significantly lower than
that of PDD caregivers but not significantly higher than
PD-N carers. Levels of ZBI in the PD-MCI and PDD
caregivers reported by Leroi (23.61 and 35.48) respec-
tively, were similar to the differences found in the
current study (22.00 and 29.33). One disparity compared
to the current study was higher levels of burden re-
ported by PD-N caregivers (20.00) in the Leroi study.
Perhaps Leroi’s predominantly male caregivers found the
caregiving role demanding in the early stages of PD, al-
though previous research suggests female caregivers ex-
perience higher perceived burden [30] and we found no
significant gender differences in the extent to which the
current study’s PD-N male and female caregivers re-
ported ZBI [t(49) = .88, p = .38]. Another possible ex-
planation for the contrasting finding is that continuous
involvement in the New Zealand Brain Research’s longi-
tudinal study has provided a sense of support to the
caregivers of PD-N patients involved in this research
and has thereby lowered their feelings of burden. Also
relevant is that the PD-MCI criteria used in the current
study is associated with high levels of conversion to
PDD over a four-year period [4].
The study by Szeto et al. [10] compared caregivers for
PD-N and PD-MCI patients only. While the authors re-
ported significantly lower quality of life scores with re-
gard to physical health and interruptions to usual
activities among PD-MCI caregivers, they mention that
there was no difference in caregiver burden. They did
not, however, report the actual levels of burden, but
stated that the results were similar to those of Leroi et
al. [9] These two studies used level I criteria to establish
PD-MCI status, whereas the current study employed the
more comprehensive level II criteria, which has been
shown to be suitable in terms of stability and in-
creased risk of progression to PDD [4]. Also, level I
criteria may underestimate the proportion of PD-MCI
patients and thus misclassify some PD-MCI patients
as PD-N [31]. In another study of PD carers Lawson
et al. [8] used a range of cognitive tests, though using
modified Level II criteria, to identify PD-MCI pa-
tients. Lawson et al. reported that quality of life
scores for PD-MCI carers were intermediate to that
of caregivers for patients classified as PD-N (higher)
and PDD (lower). Their results support the findings
of the current study, which identified intermediate
levels of distress among PD-MCI caregivers relative to
caregivers of patients meeting PDD and PD-N classifi-
cation. Unlike the Lawson study we were unable to
find support that attentional deficits were related to
caregiver distress.
Fig. 1 Standardized regression coefficients for the relationship between PD patient cognitive status and caregiver burden as mediated by use of
problem-focused, emotion-focused and dysfunctional coping strategies (n = 96). The standardized regression coefficients between cognitive
status and burden controlling for coping strategies are in parentheses *p < .05, **p < .01, ***p < .001
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Elevated burden among PDD caregivers in the current
study compared with PD-N caregivers is consistent with
previous research. Indeed 80% of PDD caregivers scored
above the 21-point threshold on the ZBI, indicating mild
to severe burden [13]. This threshold of burden was also
frequent in PD-MCI caregivers (60%), and even apparent
in a substantial number of caregivers of PD-N patients
(30%) [11]. Given the high rates of burden irrespective
of cognitive status, it is possible that neuropsychiatric
and motor symptoms associated with PD and disease
progression play a significant part towards negative care-
giver outcomes. The significant effects of PD patient
cognitive status nonetheless remained significant after
controlling for neuropsychiatric symptoms and motor
severity even though these features increased progressively
with worsening cognition. Notably caregiver burden was
also independent of disease duration. The difference in
the number of hours spent caregiving between the three
patient cognitive status groups suggests that even in the
early stages of the disease the presence of impaired
cognition places an additional load on caregivers. These
observations lend support for the notion of PD-MCI as a
clinical identity that has a significant impact not just on
the person with PD but also the primary carer.
This is the first study to examine caregiver coping
strategies as potential mediators of the relationship bet-
ween patients’ cognitive status and caregiver burden in
PD. The use of all three coping strategies increased as
the patient’s cognitive status worsened. However, no evi-
dence was found to suggest that the use of any of these
coping strategies reduced caregiver burden in the
current study. In fact, increased use of all three coping
strategies was related to higher burden scores across the
whole PD sample. For dysfunctional coping (disengaging
from the situation or emotions) these findings are in line
with other studies on dementia [14], and for problem-
focused coping these findings add to a growing literature
suggesting that responding with problem-focused stra-
tegies to situations that are beyond one’s control, such
as when caring for an individual with a deteriorating ill-
ness, may not be effective [19]. For emotion-focused
coping, however, these findings are not in line with stu-
dies of dementia caregivers showing that emotion-
focused coping (managing one’s emotional response to
stress) was associated with better caregiver outcomes
(lower levels of anxiety and depression) [14]. Because of
its correlational design the current study was unable to
draw conclusions about causality. Although the three
coping strategies mediated the relationship between cog-
nitive status and caregiver burden, the reverse causation
models (with burden mediating the relationship between
cognitive status and coping) were also significant. The
complex and possibly bidirectional relationship between
caregiver outcomes and coping strategies was also
illustrated in a longitudinal study of dementia caregivers
by Cooper et al. [19]. They found that cross-sectionally
caregiver burden was related to increased emotion-
focused, problem-focused and dysfunctional coping (in
line with findings from the current study), but that lon-
gitudinally an increased use of emotion-focused coping
was related to lower anxiety.
Limitations
Further evidence on burden and coping strategies in
PD-MCI patients is needed because the current study
had a relatively low number of participants and group
sizes differed. Another limitation is the cross-sectional
design. Longitudinal data could better assess the tem-
poral course of caregiver outcomes and disentangle the
directional causality between ZBI, cognitive impairment
and coping strategies.
Conclusions
The current study showed that caregivers of PD-MCI
patients, known to have a high risk of dementia, often
experience high levels of burden. PD without cognitive
impairment is less often associated with caregiver burden,
but this is also apparent even in a subset of these carers.
The association between cognitive impairment and care-
giver burden is relatively independent of neuropsychiatric
and motor symptoms, disease duration and patient ability
to engage in tasks of daily living. The findings add weight
to the need for greater awareness of cognitive decline in
PD patients and in particular to provide better support
frameworks for caregivers before the onset of dementia.
Increased support for caregivers may benefit patients and
help delay the need for nursing home placement.
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